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Using a synthetic oligonucleotide primer complementary to human prostate-specific antigen mRNA, we found that an 
additional sequence possibly similar to human glandular kallikrein-1 could be read by a primer-extension sequencing 
technique. We were able to confirm the identity of that additional sequence with another oligonucleotide primer comple- 
mentary to a specific region of the human glandular kallikrein-I mRNA sequence. Northern blot analysis with 2 oligonu- 
cleotide probes respectively specific for prostate-specific antigen and human glandular kallikrein-1 mRNAs showed that 
the length of both mRNAs was similar at 1.5 kb. The level of human glandular kallikrein-1 mRNA relative to that of 
prostate-specific antigen could be estimated as approx. l&20$. This study constitutes the first evidence that the human 
glandular kallikrein-I gene is expressed at a high level in a human tissue. 
Prostate cancer; Proteolytic enzyme, Trypsin-like enzyme; Chymotrypsin-like enzyme 
1. INTRODUCTION 
Before this study, the only kallikrein-related 
mRNA known to be expressed in the human 
prostate was PSA mRNA [l]. PSA is a 
chymotrypsin-like enzyme secreted as a major 
component of seminal plasma [2]. One of its possi- 
ble roles is the dissolution of the seminal coagulum 
formed upon ejaculation [3]. This protein has 
generated tremendous interest in recent years and 
indeed has become the marker of choice to 
monitor therapy for prostatic carcinoma [4]. Its 
primary structure has been determined by both 
classical amino acid sequencing [5,6] and 
nucleotide sequencing of a cDNA clone [ 11. In the 
latter study, the cDNA clone lacked a small por- 
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tion of the 5 ‘-terminus coding both for un- 
translated sequences and for the first amino acids 
of the signal peptide. While we were conducting 
studies to determine the unknown 5 ‘-end se- 
quences by a primer-extension technique, we ob- 
tained evidence that hGK-1 mRNA was also 
expressed at a high level in the human prostate. 
The putative kallikrein encoded by this mRNA 
contains structural features of trypsin-like pro- 
teases [7]. 
2. MATERIALS AND METHODS 
2.1. Reagents 
RAV2 reverse transcriptase and [y-32P]ATP (5000 Ci/mmol) 
were obtained from Amersham. Td polynucleotide kinase was 
purchased from Bethesda Research Laboratories (BRL). Calf 
liver tRNA and E. coli 600 tRNA were obtained from Boeh- 
ringer Mannheim. 
2.2. mRNA isolation 
Human prostatic tissues were obtained from 2 patients 
undergoing surgical treatment for benign prostatic hyper- 
trophy. Other human tissues were obtained at autopsy of a 
55-year-old man who died from a myocardial infarctus. Total 
RNA was isolated by the method of Chirgwin et al. (81. The 
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poly(A)+ RNA fraction was recovered after two passages of 
total RNA over a small oligo-d(T)-cellulose column (BRL). 
3. RESULTS 
2.3. RNA sequencing 
Specific oligonucleotide primers were chemically synthesized 
using a Biosearch model 8700 DNA synthesizer (New 
Brunswick Scientific). All primers were purified by polyacryl- 
amide gel electrophoresis. RNA sequencing using poly(A)+ 
RNA was performed by the primer-extension technique recently 
described by Geliebter et al. [9]. For each sequence reaction 
5 ,ug poly(A)’ RNA were used with 5 ng of one specific 
oligonucleotide primer radiolabeled with [Y-~~P]ATP using T4 
polynucleotide kinase. Annealing temperatures varied between 
57 and 65°C depending on the specific nucleotide content ac- 
cording to the formula: T(“C) = 4(G + C’) + 2(A + 7) - 5. 
The first experiment of this study was designed 
to determine the oligonucleotide sequence of the 
5’-portion of human PSA mRNA which was miss- 
ing from clone /\-HPSA-1 isolated and sequenced 
by Lundwall and Lilja [l]. For this purpose, we 
synthesized an oligonucleotide primer designated 
TrBlO (table 1) and complementary to the mRNA 
nucleotide sequence of PSA [ 11. Primer-extension 
sequencing of prostatic mRNA using TrBlO (not 
shown) indicated that beside PSA, we could read 
2.4. Norihem blots with synthetic oligonucleotides 
5 ,ug poly(A)+ RNA from human prostate, liver, kidney and 
testis were denatured in 6% formaldehyde and 50% formamide 
in 1 x Mops buffer and were applied on 1.2% agarose gels con- 
taining 2% formaldehyde and 1 x Mops. Electrophoresis was 
carried out at 100 V for 4-5 h. RNA was transferred and fixed 
on Hybond N nylon membrane (Amersham) as suggested by the 
supplier. Prehybridization was performed in 6 x SSC, 1 mM 
EDTA, 5 x Denhardt, 0.5% SDS, lOOpg/ml of MRE 600 
tRNA and 20 mM Tris-HCl (pH 7.4) for at least 2 h at the same 
temperature as that used during the hybridization per se. 
Hybridization was done in fresh buffer also containing 10% 
dextran sulfate and one of the radiolabeled oligonucleotide 
probes described in section 3. These probes were labeled with 
[y-‘*P]ATP similarly to the RNA sequencing reaction. The 
probes were immediately purified by precipitation in the 
presence of 25 pg calf liver tRNA using 2.5 M ammonium 
acetate and 2.5 vols of 95% ethanol. Hybridization was per- 
formed at 58°C over 16-18 h w-ith one specific oligonucleotide 
probe (4-6 x lo6 cpm/ml). The filters were then washed at 
54°C for 1 h in 2 x SSC, 10 mM Tris-HCI (pH 7.5), 0.5% SDS 
and then for 1 h more in 1 x SSC, 10 mM Tris-HCl (pH 7.5) 
and 0.5% SDS. Finally, the filters were air-dried for 1 min and 
placed between two layers of Saran wrap. Autoradiography was 
carried out on Kodak X-Omat AR XR2 film at -80°C. 
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Table 1 
Oligonucleotide primers” complementary to PSA and hGK-1 
mRNAs 
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Designation Oligonucleotide primers 
TrBlO 5 ‘GGGTTGGGAATGCTTCTCGCA-3 ’ 
TrB13 5 ‘-TTCTGAGGGTGAACTTGCGCAJ ’ 
TrB14 5 ’ -CCTGCCACGAGAGGCCACAAG-3 ’ 
TrB15 5’-CTTCTCAGAGTAAGCTCTAGC-3’ 
a TrBlO, TrB13 and TrB14 are complementary to mRNA 
sequences of PSA coding respectively for amino acids 
7-13 (CEKHSQP), 161-167 (AQVHPQK) and 17-23 
(LVASRGR). TrB15 is complementary to the deduced mRNA 
sequence from the hGK-1 gene and codes for putative amino 
acids 161-167 (ARAYSEK). The amino acid numbering is 
identical to that used in [7,8] 
TrBlS (hGK-1) TrB13 (PSA) 
Fig.1. Primer-extension determination of the nucleotide 
sequence of PSA and hGK-1 mRNAs using 21-mer specific 
oligonucleotide primers, TrB13 and TrB15. For the sake of 
clarity, nucleotides corresponding to the DNA sequence are 
shown here instead of the observed complementary nucleotides 
of the primer-extended reaction. Arrowheads indicate the 
nucleotides which are divergent between the 2 sequences. The 
lengths of the 2 sequencing gels were slightly different as a result 
of 2 separate runs being carried out. 
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Fig.2. Northern blot analysis of PSA and hGK-1 mRNAs using 
oligonucleotide primers TrB13 and TrB15 as hybridization 
probes. The specific activity of each radiolabeled probe and the 
amount of radioactivity in each hybridization solution were 
identical. Autoradiography on X-ray films was performed for 
3 h. 
an additional sequence that was compatible with 
that recently published of the hGK-1 gene [7]. In 
order to confirm this result, we synthesized 2 
oligonucleotide primers, TrB 13 and TrB 15, which 
were specific respectively for PSA and hGK-1 (see 
table 1) and performed primer-extension sequenc- 
ing using prostatic poly(A)+ RNA. The results are 
shown in fig.1. The portion of the sequencing gel 
shows that 12 nucleotides out of 59 were different 
between the 2 sequences. The whole sequences ob- 
tained with primers TrB13 and TrB15, respective- 
ly, were identical to those of PSA [l] and hGK-1 
[7]. These results prompted us to determine 
whether both mRNAs had a similar length and 
what were their relative concentrations with 
respect to each other in the prostate and in other 
human tissues. Northern blot analysis using the 2 
specific oligonucleotide primers as hybridization 
probes showed that the mRNAs for PSA and 
hGK-1 had an identical size of approx. 1.5 kb 
(fig.2). Image analysis by densitometric scanning 
indicated that the intensity of the hGK-1 1.5 kb 
PSA ‘XTACCACCTGCACCCCGAGAGCTGTGTCACC AK TGG GTC CCG 4 
hGK-1 TGCACCACCTGGCCGTGGACACCTGTGTCAGC AX TGG GAC C-K 44 
IIrJ 9 av k” 
-24 -7.1 
Fig.3. Comparative 5’-terminal nucleotide sequence of the 
DNA encoding PSA determined in this study by primer 
extension with TrB14 and of the DNA sequence of hGK-1 
determined by Schedlich et al. [8]. Further downstream,*the 
nucleotide sequence of PSA that could be read was identical to 
that of Lundwall and Lilja [7]. 
band varied from 10 to 20% relative to PSA 
depending on the experiment. These mRNAs ap- 
pear to be absent from the liver, kidney and testis. 
In order to determine specifically the unknown 
5 ‘-terminal nucleotide sequence of PSA we used 
another oligonucleotide primer, TrB14, com- 
plementary to PSA mRNA in a region highly 
divergent from the one of hGK-1 (table 1). This 
oligonucleotide primer was used for sequencing 
PSA mRNA by primer extension. The comparative 
5 ‘-terminal nucleotide sequences of PSA and 
hGK-1 are shown in fig.3. The 5’-untranslated 
region of PSA mRNA contains 32 nucleotides and 
has 69% homology with that of hGK-1. By con- 
trast, the two prepro pieces are only 54% 
homologous (not shown). 
4. DISCUSSION 
This study constitutes the first evidence that 
hGK-1 mRNA is expressed in a human tissue. 
Schedlich et al. [7] have determined the structure 
of the hGK-1 gene, but have not studied its expres- 
sion. Furthermore, the putative glandular kalli- 
krein encoded by this gene has never been isolated 
from the prostate. The deduced amino acid se- 
quence of hGK-1 [7] predicts that the encoded pro- 
tein has a trypsin-like specificity whereas PSA has 
a chymotrypsin-like specificity [6]. There are some 
indications in the literature that hGK-1 may be pre- 
sent as a variable contaminant in preparations of 
PSA. Indeed, in some studies purified prostate- 
specific antigen showed low but detectable activity 
towards synthetic substrates of both trypsin and 
chymotrypsin [5]. In other studies, the purified 
preparation was active against argininellysine- 
containing substrates, but not against a 
chymotrypsin substrate, benzoyltyrosine ethyl 
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chymotrypsin-like activity. For these reasons and 
because of high concentrations of hGK-1 mRNA 
in human prostate, we propose that hGK-1 may be 
a relatively abundant secretory protein of the pro- 
state. This proposition has important implications 
for the interpretation of presently available and 
widely used immunoassay procedures for serum 
PSA in prostatic cancer patients. The specificities 
of the various antibodies used are not known and 
could be directed variably towards hGK-1 and 
PSA. Since the expression of various prostatic 
secretory proteins does not follow a parallel trend 
in prostatic cancer cells and since the various 
markers are not equivalent [lo], it will become im- 
portant to isolate hGK-1 and PSA uncontaminated 
by each other, to develop specific antibodies for 
both proteins and to determine their respective 
usefulness for the diagnostic and follow-up of pro- 
state cancer patients. 
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